ArticleDiabetes, obesity & metabolism2026
Clarity in Reporting Multiple Long-Term Conditions in Research: The Need for Consistency and Consensus.
Article in Diabetes, obesity & metabolism, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Multiple long-term conditions (MLTC), also known as multimorbidity, affects a substantial proportion of the global population and represents an increasing challenge to healthcare systems, individuals and society. Despite increasing attention and investment, progress in MLTC research is hindered by conceptual inconsistencies and a lack of standardised reporting. Challenges include varied terminology, differing definitions of chronicity and substantial variation in the number and type of conditions included across studies. These inconsistencies contribute to differences in prevalence estimates and reduced comparability across the literature. Moreover, many clinical trials involve participants living with MLTC but do not collect or report co-existing conditions, leaving their experiences largely invisible within research and limiting applicability of findings for this population. Heterogeneity in disease clusters and outcome selection further complicates evidence synthesis. In this commentary, we highlight that improving the clarity and impact of MLTC research requires transparent reporting of MLTC status, the use of consensus-based condition lists, identification of clinically and socially meaningful clusters and prioritisation of outcomes aligned with what matters most to people living with MLTC (e.g., independence, treatment burden and quality of life). Improving reporting practices is needed to generate evidence that improves care, informs policy and enhances the wellbeing of people living with MLTC.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.